Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2009 | 2 |
2011 | 1 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
Cediranib: profile of a novel anti-angiogenic agent in patients with glioblastoma.
Expert Opin Investig Drugs. 2009 Oct;18(10):1549-57. doi: 10.1517/13543780903183528.
Expert Opin Investig Drugs. 2009.
PMID: 19671039
Free PMC article.
Review.
Serial magnetic resonance spectroscopy reveals a direct metabolic effect of cediranib in glioblastoma.
Kim H, Catana C, Ratai EM, Andronesi OC, Jennings DL, Batchelor TT, Jain RK, Sorensen AG.
Kim H, et al.
Cancer Res. 2011 Jun 1;71(11):3745-52. doi: 10.1158/0008-5472.CAN-10-2991. Epub 2011 Apr 20.
Cancer Res. 2011.
PMID: 21507932
Free PMC article.
Clinical Trial.
Item in Clipboard
Edema control by cediranib, a vascular endothelial growth factor receptor-targeted kinase inhibitor, prolongs survival despite persistent brain tumor growth in mice.
Kamoun WS, Ley CD, Farrar CT, Duyverman AM, Lahdenranta J, Lacorre DA, Batchelor TT, di Tomaso E, Duda DG, Munn LL, Fukumura D, Sorensen AG, Jain RK.
Kamoun WS, et al.
J Clin Oncol. 2009 May 20;27(15):2542-52. doi: 10.1200/JCO.2008.19.9356. Epub 2009 Mar 30.
J Clin Oncol. 2009.
PMID: 19332720
Free PMC article.
Item in Clipboard
Cite
Cite
ARTICLE TYPE
ARTICLE LANGUAGE
AGE
Filters on the sidebar will be reset to the default list and any currently applied filters will be cleared.